U S LABORATORIES INC
3, 1999-02-23
TESTING LABORATORIES
Previous: PENNZOIL QUAKER STATE CO, S-8, 1999-02-23
Next: U S LABORATORIES INC, 3, 1999-02-23




       FORM 3                                            OMB APPROVAL     
                                                                       
                                                    OMB Number        3235-0104
                                                    Expires  September 30, 1998
                                                    Estimated average burden
                                                    hours per response .....0.5


                     U.S. SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC. 20549

             INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
                                                                       
     Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
                       Section 17(a) of the Public Utility

         Holding Company Act of 1935 or Section 30(f) of the Investment
                               Company Act of 1940


(Print or Type Responses)
- --------------------------------------------       
1. Name and Address of Reporting Person              2. Date of Event-        
                                                        Requiring Statement
              Fuchs Irvin J.                            (Month/Day/Year)    
- --------------------------------------------                 2/23/99  
(Last)          (First)           (Middle)              
                                                                             
            28 Hillcrest Road                                            
- -------------------------------------------- 
                (Street)                             3. IRS or Social Security
                                                        Number of Reporting  
       Cedar Grove, New Jersey 07009                    Person (Voluntary)
- -------------------------------------------- 
(City)          (State)            (Zip)


4.   Issuer Name and Ticker or Trading Symbol
                                             
          U.S. Laboratories Inc. (USLB)      
                                             
                                                                
5.   Relationship of Reporting Person                6. If Amendment, Date of 
     to Issuer                                          Original       
         (Check all applicable)                         (Month/Day/Year) 
                                                   
     |X|Director              [ ]10% Owner         
     [ ]Officer (give         [ ]Other (specify   
                 title below)           below)    

          ___________________

 7.   Individual or Joint/Group Filing
      (Check Applicable Line)                   
      |X|     Form filed by One Reporting Person   
      ___     Form filed by More than One Reporting
              Person             
                            

<TABLE>
<CAPTION>
                                Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security               2. Amount of             3. Ownership          4. Nature of Indirect Beneficial Ownership
   (Instr. 4)                         Securities               Form:  Direct         (Instr. 5)
                                      Beneficially             (D) or            
                                      owned                    Indirect          
                                      (Instr. 4)               (I) (Instr. 5)    
<S>                                <C>                      <C>                   <C>

                                                                                 
                                                                                 
                                                                                 
                                                                                 
                                                                                 
                                                                                 
                                                                                 
                                                                                 
                                                                                 
</TABLE>                                                                     
                          
Reminder:  Report on a separate line for each class of securities beneficially
           owned directly or indirectly.
*   If the form is filed by more than one reporting person, see instruction 
    5(b)(v).
<PAGE>
FORM 3 (continued)

<TABLE>
<CAPTION>
       TABLE II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

- --------------------------------- ----------------- ----------------------------------- ----------- ------------ -------------------
1. Title of Derivative Security   2. Date Exer-     3. Title and Amount of Securities   4. Conver-  5. Owner-      6. Nature of
   (Instr. 4)                        cisable and       Underlying                          sion or     ship           Indirect      
                                     Expiration        Derivative Security                 Exercise    Form of        Beneficial  
                                     Date              (Instr. 4)                          Price       Deri-          Ownership
                                     (Month/Day/Year)                                      of          vative         (Instr. 5)
                                                                                           Deri-       Security:
                                                                                           vative      Direct   
                                                                                           Security    (D) or   
                                                                                                       Indirect 
                                                                                                       (I)(Instr.
                                                                                                       5)
- --------------------------------- ----------------- ----------------------------------- ----------- ------------ -------------------
                                                                               Amount
                                  Date       Expira-                           or
                                  Exer-      tion              Title           Number
                                  cisable    Date                              of
                                                                               Shares
- --------------------------------- --------   -------- ------------------------ -------- ----------- ------------ -----------------
<S>                               <C>        <C>      <C>                      <C>      <C>         <C>          <C>
Incentive Stock Options           11/10/98*  11/10/03      Common Stock          5,000    $6.00          D
- --------------------------------- --------   -------- ------------------------ -------- ----------- ------------ -----------------

- --------------------------------- --------   -------- ------------------------ -------- ----------- ------------ -----------------

- --------------------------------- --------   -------- ------------------------ -------- ----------- ------------ -----------------

- --------------------------------- --------   -------- ------------------------ -------- ----------- ------------ -----------------

- --------------------------------- --------   -------- ------------------------ -------- ----------- ------------ -----------------

Explanation of Responses:

*Provided Mr. Fuchs is serving as a Director of the Company or its subsidiaries.


</TABLE>
                                   /S/  Irvin J. Fuchs                2/23/99
                             **  Signature of Reporting Person          Date



**Intentional misstatements or omissions of 
  facts constitute Federal Criminal Violations. 
   See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).    


Note: File three copies of this Form, one of which must be manually signed.
      If space provided is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.  


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission